← Back to Search

VAX-MOM Intervention for Increasing Vaccination During Pregnancy

N/A
Waitlist Available
Research Sponsored by University of Rochester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients: Sex is female
Patients
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months during the 2019-2020 flu season (baseline), compared to 6 months during the 2021-2022 flu season (intervention)
Awards & highlights
No Placebo-Only Group

Summary

This trial will test whether giving obstetricians' offices feedback on their influenza and pertussis vaccination rates will increase the rates.

Who is the study for?
This trial is for pregnant women who are eligible to receive the influenza or Tdap vaccine. It includes any provider, nurse, or staff associated with participating sites. There are no exclusion criteria for patients or providers in this study.
What is being tested?
The VAX-MOM Intervention is being tested against the standard of care to see if it can increase vaccination rates among pregnant women and reduce complications from flu and pertussis infections.
What are the potential side effects?
Typical side effects of vaccines like influenza and Tdap may include soreness at injection site, mild fever, fatigue, headache, muscle pain. Serious side effects are rare but can include allergic reactions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am female.
Select...
It seems like your message was cut off. Could you please provide more details or context so that I can assist you effectively?
Select...
I am female.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months during the 2019-2020 flu season (baseline), compared to 6 months during the 2021-2022 flu season (intervention)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months during the 2019-2020 flu season (baseline), compared to 6 months during the 2021-2022 flu season (intervention) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in the rate of Tdap vaccination
Change in the rate of influenza vaccination

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: VAX-MOM InterventionExperimental Treatment1 Intervention
Group II: Standard of CareActive Control1 Intervention

Find a Location

Who is running the clinical trial?

University of RochesterLead Sponsor
871 Previous Clinical Trials
539,915 Total Patients Enrolled
Centers for Disease Control and PreventionFED
892 Previous Clinical Trials
21,990,991 Total Patients Enrolled
University of California, Los AngelesOTHER
1,567 Previous Clinical Trials
10,257,097 Total Patients Enrolled

Media Library

Standard of Care Clinical Trial Eligibility Overview. Trial Name: NCT04444518 — N/A
Pregnancy Research Study Groups: VAX-MOM Intervention, Standard of Care
Pregnancy Clinical Trial 2023: Standard of Care Highlights & Side Effects. Trial Name: NCT04444518 — N/A
Standard of Care 2023 Treatment Timeline for Medical Study. Trial Name: NCT04444518 — N/A
~1948 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top